Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder
Basic and Clinical Neuroscience Journal · 01.03.2026 · 17 (2) · 337-344
DOI: 10.32598/bcn.2026.8104.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic and Clinical Neuroscience Journal, erschienen am 01.03.2026. Verfasst von Mohammad Saeed Maniati und 2 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Introduction
This study aimed to compare the efficacy of three common selective serotonin reuptake inhibitors (SSRIs)—fluoxetine, fluvoxamine, and sertraline—in treating anxiety disorders, major depressive disorder (MDD), and obsessive-compulsive disorder (OCD).
Methods
This eight-week randomized controlled clinical trial included 90 participants who were randomly assigned to receive either fluoxetine (20 mg), ...
Zitieren
APA
Maniati, M. S., Khosrowabadi, R., & Shams, J. (2026). Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder. Basic and Clinical Neuroscience Journal, 17(2), 337-344. https://doi.org/10.32598/bcn.2026.8104.1
Vancouver
Maniati MS, Khosrowabadi R, Shams J. Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder. Basic and Clinical Neuroscience Journal. 2026;17(2):337-344. doi:10.32598/bcn.2026.8104.1
BibTeX
@article{Maniati2026,
author = {Maniati, Mohammad Saeed and Khosrowabadi, Reza and Shams, Jamal},
title = {Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder},
journal = {Basic and Clinical Neuroscience Journal},
year = {2026},
volume = {17},
number = {2},
pages = {337--344},
doi = {10.32598/bcn.2026.8104.1}
}
EUVIMED